Suppr超能文献

降钙素离子对的口服给药:一种高亲脂性抗衡离子的体内概念验证。

Oral delivery of calcitonin-ion pairs: In vivo proof of concept for a highly lipophilic counterion.

作者信息

Wibel Richard, Jörgensen Arne Matteo, Laffleur Flavia, Spleis Helen, Claus Victor, Bernkop-Schnürch Andreas

机构信息

Department of Pharmaceutical Technology, University of Innsbruck, Institute of Pharmacy, Center for Chemistry and Biomedicine, 6020 Innsbruck, Austria.

Department of Pharmaceutical Technology, University of Innsbruck, Institute of Pharmacy, Center for Chemistry and Biomedicine, 6020 Innsbruck, Austria; Thiomatrix Forschungs-und Beratungs GmbH, Trientlgasse, 65, 6020 Innsbruck, Austria.

出版信息

Int J Pharm. 2023 Jan 25;631:122476. doi: 10.1016/j.ijpharm.2022.122476. Epub 2022 Dec 14.

Abstract

Hydrophobic ion pairing and subsequent incorporation into self-emulsifying drug delivery systems (SEDDS) is a promising strategy to orally deliver hydrophilic macromolecular drugs. Within this study, hydrophobic ion pairs (HIP) between salmon calcitonin (sCT) and highly lipophilic sulfosuccinate counterions were formed and compared to frequently applied commercially available counterions. Bis(isotridecyl) sulfosuccinate resulted in HIPs of the highest lipophilicity and in significantly higher solubility in lipophilic co-solvents. Thus, bis(isotridecyl) sulfosuccinate allowed efficient solubilization of sCT in a SEDDS preconcentrate based on a lipophilic co-solvent and an indigestible lipid, but omitting hydrophilic co-solvents. In addition to the increased solubility in the lipidic matrix, markedly reduced dissociation in biorelevant media resulted in high distribution coefficients between oil droplet and FaSSGF or FaSSIF (logD) of 2.98 ± 0.12 or 2.77 ± 0.14, respectively. The composition of the lipidic matrix preserved integrity of the oil droplets after emulsification and subsequent lipolysis, allowing to fully exploit the potential of the HIP attributed to the high logD. Oral administration of the HIP-loaded SEDDS resulted in an excellent relative pharmacological activity of 13.8 ± 5.6 % measured as hypocalcaemic effect in rats.

摘要

疏水离子对形成并随后掺入自乳化药物递送系统(SEDDS)是口服递送亲水性大分子药物的一种有前景的策略。在本研究中,形成了鲑鱼降钙素(sCT)与高度亲脂性磺基琥珀酸抗衡离子之间的疏水离子对(HIP),并与常用的市售抗衡离子进行了比较。双(异十三烷基)磺基琥珀酸产生了亲脂性最高的HIP,并且在亲脂性助溶剂中的溶解度显著更高。因此,双(异十三烷基)磺基琥珀酸能够在基于亲脂性助溶剂和难消化脂质但不含亲水性助溶剂的SEDDS预浓缩物中有效地增溶sCT。除了在脂质基质中溶解度增加外,在生物相关介质中解离明显减少,导致油滴与FaSSGF或FaSSIF之间的分配系数较高(logD),分别为2.98±0.12或2.77±0.14。脂质基质的组成在乳化和随后的脂解后保持了油滴的完整性,从而能够充分发挥归因于高logD的HIP的潜力。口服负载HIP的SEDDS导致大鼠降血钙作用的相对药理活性优异,为13.8±5.6%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验